All lobbying filings

TARPLIN, DOWNS & YOUNG, LLC

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $80,000.00 income · posted Jan 20, 2026

Official filing document

Lobbying activity 3

Budget/Appropriations

Federal budget issues

Health Issues

Alternatives to PAIN Act, IRA, innovation, health disparities, orphan drugs, drug pricing in federal programs, opioid alternative medicines, SUPPORT Act reauthorization, awareness of rare kidney disorders

Medicare/Medicaid

Medicare & Medicaid payment and coverage issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.